The Science - - BioPharm International


The Science

BioPharm International

TABLE 1: Approximate times from introduced gene to protein production at usable levels.
Animal cells are much more fragile. They are often much larger than any microorganism and evolved to live in a collective as part of organs or tissues within complex anatomical systems. They are held together only by a delicate membrane, they are more difficult to grow in suspension, and they often have to grow attached to surfaces. These cells are complex, with systems of cellular machinery inside of them. Animal cells replicate slowly, require complex nutrients, and do not grow as well at high densities because of waste accumulation and oxygen stress. Animal cell culture is more complicated and thus more expensive than traditional fermentation.

But ease of growing cells is not the only issue. Yeasts and bacteria may be easy to grow, but there are limits on the size of genes that can be planted in them. If it is necessary to clone a larger chunk of DNA, then it may be necessary to use animal or plant cells.

In addition, though various kinds of cells can all be made to express the same protein, a protein produced by a bacterium may have different effects than the same protein produced by animal cells. Why? After a protein is expressed in the cell, it goes through a process called posttranslational modification. Molecules of sugars and carbohydrates attach themselves to the protein (a process called glycosylation). The protein may fold itself into a different configuration, changing the surface available to attach to other molecules in the body. Folding and glycosylation have a great effect on the ability of a protein to be used for a particular process, and different types of cells perform these modifications in different ways. The choice of the right cell to culture may result in a protein that is more appropriate for use — or in the elimination of extra steps in the manufacturing process.

Some cells express a protein of interest and then keep it within their cellular membranes. Others secrete the protein, transporting it across those membranes into the liquid the cell is growing in. For biotechnology, secreted proteins are preferred because they are easier and more cost-effective to collect and purify.

What follows is a brief introduction to the types of cells currently used in biopharmaceutical production. A more detailed discussion of the pluses and minuses of particular cells and processes can be found.

But first, a note on terminology: In discussions of biotechnology, you will hear the process of growing cells referred to as both fermentation and cell culture. The terms are close in meaning, but the biopharmaceutical industry tends to distinguish between them, using fermentation to refer to the cultivation of single-celled organisms such as bacteria and yeast, and cell culture to describe a specific kind of fermentation used to grow cells that come from multicelluar organisms such as animals and plants.

Bacteria. Many biopharmaceuticals are produced by bacteria, especially the species Escherichia coli and Bacillus subtilus.

The DNA in bacteria occurs on a single circular chromosome and in small ring-like plasmids. These circular shapes keep the DNA safe from fraying at the ends, and they can be taken up and used by many kinds of cells, which makes them convenient for use as cloning vectors.

blog comments powered by Disqus



Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines
Source: BioPharm International,
Click here